Followers | 246 |
Posts | 49790 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Sunday, January 07, 2024 12:58:26 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent OGN News
- Organon Reports Results for the First Quarter Ended March 31, 2024 • Business Wire • 05/02/2024 11:30:00 AM
- Prolia ® とXgeva ® (デノスマブ)との第3相比較臨床試験でバイオシミラー候補HLX14が主要評価項目を達成 • Business Wire • 04/09/2024 12:13:00 PM
- L'essai clinique comparatif de phase 3 du candidat biosimilaire de Prolia ® et de Xgeva ® (denosumab) HLX14 remplit les critères d'évaluation primaires • Business Wire • 04/08/2024 06:31:00 PM
- Klinische Phase-3-Vergleichsstudie zwischen Prolia ® und Xgeva ® (Denosumab) - Biosimilar-Kandidat HLX14 erreicht primäre Endpunkte • Business Wire • 04/08/2024 06:31:00 PM
- Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024 • Business Wire • 04/08/2024 10:15:00 AM
- Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints • Business Wire • 04/08/2024 10:00:00 AM
- On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health • PR Newswire (Canada) • 03/08/2024 02:01:00 PM
- À l'occasion de la Journée internationale des femmes, Organon Canada encourage les entreprises à Investir en elle et à lutter contre les inégalités entre les genres par la santé des femmes • PR Newswire (Canada) • 03/08/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:24:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:24:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:22:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:22:33 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 01:10:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 04:46:59 PM
- Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary • Business Wire • 02/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:48:45 PM
- Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023 • Business Wire • 02/15/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:16:06 PM
- Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024 • Business Wire • 02/01/2024 12:30:00 PM
- Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older • Business Wire • 01/10/2024 12:33:00 PM
- Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook • Business Wire • 01/08/2024 12:30:00 PM
- Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/21/2023 12:30:00 PM
- Organon et Lilly concluent un accord de commercialisation en Europe pour deux médicaments contre la migraine • Business Wire • 12/19/2023 01:30:00 PM
- Organon と Lilly、ヨーロッパで 2 種類の片頭痛薬商業化契約を締結 • Business Wire • 12/19/2023 09:11:00 AM
- Organon und Lilly schließen Vermarktungsvereinbarung für zwei Migräne-Medikamente in Europa • Business Wire • 12/19/2023 02:26:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM